Synopsis of recent research by authors named "Rizvana Ahmad"
- Rizvana Ahmad's research primarily focuses on cancer treatment methodologies, particularly in neoadjuvant chemotherapy for HER2-negative early breast cancer, as evidenced by her involvement in the ARTemis Trial which assesses the efficacy of various treatment protocols including the use of bevacizumab.
- Recent studies led by Ahmad investigate the role of biomarkers, such as FLT-PET imaging, in predicting patient response to docetaxel chemotherapy, aiming to improve therapeutic outcomes in breast cancer patients.
- Additionally, Ahmad has explored non-cancer related topics, such as the effects of HIV-1 treatment on conditions like gynaecomastia, showcasing a diverse research portfolio.